Black patients with acral lentiginous melanoma are at a higher risk of mortality than White patients, independent of known risk factors.

Medical use of prescription stimulants for ADHD increased between 2005 and 2023, but nonmedical use decreased over that time.

Some of the notable drug approvals that occurred in July 2025.

Among severely impaired and terminally ill nursing home residents, about one-third of all-cause hospitalizations were potentially avoidable.

Gestational carriers have elevated rates of mental illness compared with those carriers who conceived unassisted or by IVF.

Patients with EM or CTD-related CryoVas often experience relapse following RTX and corticosteroid-induced remission.

The Trump administration will end VA abortions for service members and beneficiaries in cases of rape, incest or to save the mother’s life.

Patients with moderate to severe and severe alopecia areata have a greater burden of comorbid atopic dermatitis than those with mild alopecia areata.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Adults engaged in risky drinking should be provided brief behavioral counseling interventions to reduce use, USPSTF says.

The majority of patients with skin of color and scalp psoriasis who were treated with guselkumab achieved significant scalp clearance.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.